News Image

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Altimmune, Inc. of Class Action Lawsuit and Upcoming Deadlines - ALT

Provided By PR Newswire

Last update: Oct 3, 2025

NEW YORK, Oct. 3, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Altimmune, Inc. ("Altimmune" or the "Company") (NASDAQ: ALT). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.

Read more at prnewswire.com

ALTIMMUNE INC

NASDAQ:ALT (10/14/2025, 11:39:09 AM)

3.8601

-0.14 (-3.5%)



Find more stocks in the Stock Screener

Follow ChartMill for more